Cancer-associated Thrombosis “What GP’s need to know”

Australie

$0

gratuit

Non accrédité

30 min

Medication Management, Oncology

0 Crédits

This course is expired! Browse All Courses
APPRENDRE ENCORE PLUS

Description du cours

Venous thromboembolism (VTE) is an unfortunately common complication in patients with active cancer. Recent studies suggest that one or more episodes of VTE is experienced by around 15% of patients with cancer throughout the course of their disease. With the recent emergence of data on the use of direct oral anticoagulants (DOACs), clinicians involved in the care of cancer patients need to be aware of treatment options for VTE.

In this 30 minute Expert Panel Discussion featuring Dr Damian Flanagan, Dr Amanda Hugman and Dr Jenny Liu, two patient cases are presented and their history, presentation, diagnosis and outcome are discussed with emphasis around optimal management of VTE during active cancer.

Also watch and participate in ‘Cancer-associated Thrombosis. Up to date knowledge for GP’s on diagnosing and treating DVT in patients with cancer.’

This educational activity was developed by MDBriefCase at the request, and with funding from BMS & Pfizer Alliance.

Détails du cours

Date d'expiration : 2023-08-12

Métiers: Physician, Specialist

Faculté

Damian Flanagan, GP, Mornington Peninsula, Victoria

Amanda Hugman, Haematologist, MBBS FRACP FRCPA MPhil

Jia (Jenny) Liu, Medical Oncologist, BMed(Hons) BMedSci(Hons) MD PhD FRACP

Accréditation

Members are able to claim CPD activity points for 1 points through ‘Quick log’ on their RACGP CPD Dashboard.

Objectif(s) d'apprentissage

Upon completion of this program, clinicians will be better able to::

  • Appreciate the prevalence and burden of venous thromboembolic disease in patients with cancer
  • Identifier risk factors associated with cancer-associated venous thromboembolism and intervene early to
    avoid unnecessary morbidity
  • Understand the recent data and guideline recommendations on the use of direct oral anticoagulants (DOACs) to treat cancer-associated venous thromboembolism
  • Understand the GP’s role in cancer-associated venous thromboembolism management
This course is expired! Browse All Courses